| pubmed-article:6402387 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6402387 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:6402387 | lifeskim:mentions | umls-concept:C1524059 | lld:lifeskim |
| pubmed-article:6402387 | lifeskim:mentions | umls-concept:C0014180 | lld:lifeskim |
| pubmed-article:6402387 | lifeskim:mentions | umls-concept:C0678879 | lld:lifeskim |
| pubmed-article:6402387 | lifeskim:mentions | umls-concept:C0015011 | lld:lifeskim |
| pubmed-article:6402387 | lifeskim:mentions | umls-concept:C0028368 | lld:lifeskim |
| pubmed-article:6402387 | lifeskim:mentions | umls-concept:C0419527 | lld:lifeskim |
| pubmed-article:6402387 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:6402387 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:6402387 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:6402387 | pubmed:dateCreated | 1983-4-15 | lld:pubmed |
| pubmed-article:6402387 | pubmed:abstractText | A combination of 1.0 mg dl-norgestrel and 0.1 mg ethinylestradiol (EE) was administered orally at 36 hours after the detection of the luteinizing hormone peak and again at 48 hours in 12 healthy volunteers with normal menstrual cycles. The effects on ovarian function were studied by comparing the daily serum levels of progesterone (P), 17 alpha-hydroxyprogesterone, and estradiol (E2) in control (placebo) and treatment cycles. Five subjects showed no significant change in the levels of these steroids but had a shortened luteal phase. The treatment significantly decreased both P and E2 levels in three subjects, while two subjects showed diminished E2 levels only. The remaining two subjects had lower P levels and fluctuating E2 patterns. Endometrial biopsies from both study cycles indicated asynchronous development of the epithelial and stromal components in the treatment cycle. These findings (abnormal luteal phase steroid levels and duration and outphased endometrial development) indicate that corpus luteum function was variously affected by the action of norgestrel-EE treatment. | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6402387 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6402387 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6402387 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6402387 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:6402387 | pubmed:issn | 0015-0282 | lld:pubmed |
| pubmed-article:6402387 | pubmed:author | pubmed-author:LingW YWY | lld:pubmed |
| pubmed-article:6402387 | pubmed:author | pubmed-author:WilsonEE | lld:pubmed |
| pubmed-article:6402387 | pubmed:author | pubmed-author:ZayidII | lld:pubmed |
| pubmed-article:6402387 | pubmed:author | pubmed-author:WrixonWW | lld:pubmed |
| pubmed-article:6402387 | pubmed:author | pubmed-author:AcornTT | lld:pubmed |
| pubmed-article:6402387 | pubmed:author | pubmed-author:PopatRR | lld:pubmed |
| pubmed-article:6402387 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6402387 | pubmed:volume | 39 | lld:pubmed |
| pubmed-article:6402387 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6402387 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6402387 | pubmed:pagination | 292-7 | lld:pubmed |
| pubmed-article:6402387 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:6402387 | pubmed:otherAbstract | PIP: A combination of 1.0 mg dl-norgestrel and 0.1 mg ethinyl estradiol (EE) was administered orally at 36 hours after detection of the luteinizing hormone peak and again at 48 hours in 12 healthy volunteers with normal menstrual cycles. The effects on ovarian functions were studied by comparing the daily serum levels of progesterone (P), 17alpha-hydroxyprogesterone, and estradiol (E2) in control (placebo) and treatment cycles. 5 subjects showed no significant changes in the levels of these steroids but had a shortened luteal phase. The treatment significantly decreased both P and E2 levels in 3 subjects, while 2 subjects showed diminished E2 levels only. The remaining 2 subjects had lower P levels and fluctuating E2 patterns. Endometrial biopsies from both study cycles indicated asynchronous development of the epithelial and stromal components in the treatment cycle. These findings (abnormal luteal phase steroid levels and duration and outphased endometrial development) indicate that corpus luteum function was variously affected by the action of norgestrel-EE treatment. | lld:pubmed |
| pubmed-article:6402387 | pubmed:meshHeading | pubmed-meshheading:6402387-... | lld:pubmed |
| pubmed-article:6402387 | pubmed:meshHeading | pubmed-meshheading:6402387-... | lld:pubmed |
| pubmed-article:6402387 | pubmed:meshHeading | pubmed-meshheading:6402387-... | lld:pubmed |
| pubmed-article:6402387 | pubmed:meshHeading | pubmed-meshheading:6402387-... | lld:pubmed |
| pubmed-article:6402387 | pubmed:meshHeading | pubmed-meshheading:6402387-... | lld:pubmed |
| pubmed-article:6402387 | pubmed:meshHeading | pubmed-meshheading:6402387-... | lld:pubmed |
| pubmed-article:6402387 | pubmed:meshHeading | pubmed-meshheading:6402387-... | lld:pubmed |
| pubmed-article:6402387 | pubmed:meshHeading | pubmed-meshheading:6402387-... | lld:pubmed |
| pubmed-article:6402387 | pubmed:meshHeading | pubmed-meshheading:6402387-... | lld:pubmed |
| pubmed-article:6402387 | pubmed:meshHeading | pubmed-meshheading:6402387-... | lld:pubmed |
| pubmed-article:6402387 | pubmed:meshHeading | pubmed-meshheading:6402387-... | lld:pubmed |
| pubmed-article:6402387 | pubmed:meshHeading | pubmed-meshheading:6402387-... | lld:pubmed |
| pubmed-article:6402387 | pubmed:meshHeading | pubmed-meshheading:6402387-... | lld:pubmed |
| pubmed-article:6402387 | pubmed:meshHeading | pubmed-meshheading:6402387-... | lld:pubmed |
| pubmed-article:6402387 | pubmed:year | 1983 | lld:pubmed |
| pubmed-article:6402387 | pubmed:articleTitle | Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium. | lld:pubmed |
| pubmed-article:6402387 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6402387 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:6402387 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| pubmed-article:6402387 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6402387 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6402387 | lld:pubmed |
